CD8A and neoplasm: DCs play a key role in presenting exogenous tumor antigens to activate cytotoxic CD8 + T cells for anti-tumor responses, with recent evidence indicating that the suppressive TME can dampen the anti-tumor response of DCs (Fu and Jiang, 2018).